InvestorsHub Logo
Followers 27
Posts 1621
Boards Moderated 0
Alias Born 05/03/2012

Re: None

Tuesday, 03/28/2023 4:24:23 AM

Tuesday, March 28, 2023 4:24:23 AM

Post# of 468227
TTTavv66 on stock twitz—-
TTTav66 3/27/23, 11:13 PM
SAVXL Excellent podcast discussion
Rett Syndrome Tomorrow:
Management Options on the Horizon
ivoox.com/rett-syndrome-tom.
..experts in Rett syndrome David N.
Lieberman, MD, PhD, and Jeffrey
Neul, MD, PhD, discuss trofinetide
and blarcamesine, 2 agents in late-
stage clinical trials as treatment
options for Rett syndrome.
Throughout their conversation, Drs
Lieberman and Neul review the
pivotal LAVENDER, DAFFODIL,
AVATAR, and EXCELLENCE trials,
including information on the safety
and efficacy profiles of trofinetide
and blarcamesine..." Bullish
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News